174 related articles for article (PubMed ID: 38016815)
1. Knockdown of HNRNPM inhibits the progression of glioma through inducing ferroptosis.
Wang J; Luo X; Liu D
Cell Cycle; 2023 Oct; 22(20):2264-2279. PubMed ID: 38016815
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y; Wu X; Zhu J; Lu R; Ouyang Y
BMC Cancer; 2023 Nov; 23(1):1120. PubMed ID: 37978473
[TBL] [Abstract][Full Text] [Related]
3. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
4. Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo.
Chen J; Li T; Zhou N; He Y; Zhong J; Ma C; Zeng M; Ji J; Huang JD; Ke Y; Sun H
J Neurooncol; 2023 Jul; 163(3):607-622. PubMed ID: 37351767
[TBL] [Abstract][Full Text] [Related]
5. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway.
Yang WH; Ding MJ; Cui GZ; Yang M; Dai DL
Biomed Pharmacother; 2018 Sep; 105():848-855. PubMed ID: 30021377
[TBL] [Abstract][Full Text] [Related]
7. Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma.
Chen Y; Li N; Wang H; Wang N; Peng H; Wang J; Li Y; Liu M; Li H; Zhang Y; Wang Z
Life Sci; 2020 Apr; 247():117425. PubMed ID: 32057904
[TBL] [Abstract][Full Text] [Related]
8. GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
Wei S; Yu Z; Shi R; An L; Zhang Q; Zhang Q; Zhang T; Zhang J; Wang H
BMC Cancer; 2022 Aug; 22(1):881. PubMed ID: 35962333
[TBL] [Abstract][Full Text] [Related]
9. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.
Bu C; Hu S; Yu J; Li N; Gu J; Sheng Z; Yan Z; Bu X
Clin Transl Oncol; 2023 May; 25(5):1378-1388. PubMed ID: 36484954
[TBL] [Abstract][Full Text] [Related]
10. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
Gao X; Zhao J; Jia L; Zhang Q
Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
[TBL] [Abstract][Full Text] [Related]
11. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.
Jiang Y; Zhao J; Li R; Liu Y; Zhou L; Wang C; Lv C; Gao L; Cui D
J Exp Clin Cancer Res; 2022 Oct; 41(1):307. PubMed ID: 36266731
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis model system by the re-expression of BACH1.
Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
[TBL] [Abstract][Full Text] [Related]
13. SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma.
Han L; Zhou J; Li L; Wu X; Shi Y; Cui W; Zhang S; Hu Q; Wang J; Bai H; Liu H; Guo C; Cao H; Chao M; Hu Y; Mou Y; Jiao Y; Feng D; Wang L; Qu Y
Cell Death Dis; 2022 Dec; 13(12):1071. PubMed ID: 36566214
[TBL] [Abstract][Full Text] [Related]
14. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs.
Wang C; Zhang M; Liu Y; Cui D; Gao L; Jiang Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):242. PubMed ID: 37723588
[TBL] [Abstract][Full Text] [Related]
15. Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Zhu GQ; Wang Y; Wang B; Liu WR; Dong SS; Chen EB; Cai JL; Wan JL; Du JX; Song LN; Chen SP; Yu L; Zhou ZJ; Wang Z; Zhou J; Shi YH; Fan J; Dai Z
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1413-1447. PubMed ID: 35158098
[TBL] [Abstract][Full Text] [Related]
16. GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma.
Zhou Y; Wu H; Wang F; Xu L; Yan Y; Tong X; Yan H
Front Oncol; 2021; 11():802124. PubMed ID: 35127512
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
18. hnRNPM induces translation switch under hypoxia to promote colon cancer development.
Chen TM; Lai MC; Li YH; Chan YL; Wu CH; Wang YM; Chien CW; Huang SY; Sun HS; Tsai SJ
EBioMedicine; 2019 Mar; 41():299-309. PubMed ID: 30852162
[TBL] [Abstract][Full Text] [Related]
19. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Xu Z; Chen X; Song L; Yuan F; Yan Y
Front Immunol; 2022; 13():834595. PubMed ID: 35281049
[TBL] [Abstract][Full Text] [Related]
20. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
